IDEAS home Printed from https://ideas.repec.org/r/ehl/lserod/100541.html

Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers

Citations

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Opportunity costs, marginal productivity, and cost-effectiveness thresholds: what are they and how are they related?
    by Rita Faria, Jessica Ochalek, jameslomas88 in The Academic Health Economists' Blog on 2020-09-23 06:00:00

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Basu, Anirban, 2020. "A welfare-theoretic model consistent with the practice of cost-effectiveness analysis and its implications," Journal of Health Economics, Elsevier, vol. 70(C).
  2. Marco Hafner & Erez Yerushalmi & Fredrik L. Andersson & Teodor Burtea, 2023. "Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 654-674, March.
  3. James Lomas & Jessica Ochalek & Rita Faria, 2022. "Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment," Applied Health Economics and Health Policy, Springer, vol. 20(1), pages 13-18, January.
  4. Frank H Galvan & Honghu Liu & Ronald A Brooks & Ying-Tung Chen & Ricardo Mendoza Lepe, 2022. "Using social and sexual networking mobile applications to promote HIV testing, medical care and prevention services among Latino men who have sex with men in Los Angeles County, California, USA," PLOS ONE, Public Library of Science, vol. 17(5), pages 1-18, May.
  5. Sean P. Gavan & Stuart J. Wright & Fiona Thistlethwaite & Katherine Payne, 2023. "Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review," PharmacoEconomics, Springer, vol. 41(6), pages 675-692, June.
  6. Thuy Dung Pham Thi & Van Kien Pham & Nam Tien Duong, 2025. "Impacts of Competitive Pressure and Organizational Context on Organizational Structure: A Role of Knowledge Management," SAGE Open, , vol. 15(2), pages 21582440251, May.
  7. Baudouin Standaert & Christophe Sauboin & Quentin J. Leclerc & Mark P. Connolly, 2021. "Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs," PharmacoEconomics, Springer, vol. 39(2), pages 257-269, February.
  8. Sebastian Hinde & Laura Bojke & Peter Coventry, 2021. "The Cost Effectiveness of Ecotherapy as a Healthcare Intervention, Separating the Wood from the Trees," IJERPH, MDPI, vol. 18(21), pages 1-13, November.
  9. Ana Duarte & Simon Walker & Andrew Metry & Ruth Wong & Jasmina Panovska-Griffiths & Mark Sculpher, 2021. "Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies," PharmacoEconomics, Springer, vol. 39(8), pages 879-887, August.
  10. Matthew Franklin & James Lomas & Gerry Richardson, 2020. "Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations," PharmacoEconomics, Springer, vol. 38(7), pages 665-681, July.
  11. Sebastian Hinde & Simon Walker & Hugues Lortie-Forgues, 2019. "Applying the three core concepts of economic evaluation in health to education in the UK," Working Papers 170cherp, Centre for Health Economics, University of York.
  12. Edward Cox & Simon Walker & Charlotte L. Edwardson & Stuart J. H. Biddle & Alexandra M. Clarke-Cornwell & Stacy A. Clemes & Melanie J. Davies & David W. Dunstan & Helen Eborall & Malcolm H. Granat & L, 2022. "The Cost-Effectiveness of the SMART Work & Life Intervention for Reducing Sitting Time," IJERPH, MDPI, vol. 19(22), pages 1-14, November.
  13. Zanfina Ademi & Sheridan E. Rodda & Karl Vivoda & Susan Hennessy & Olive Fenton & James S. Ware, 2025. "Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention," PharmacoEconomics, Springer, vol. 43(11), pages 1281-1292, November.
  14. David Glynn & Vijay S. Gc & Karl Claxton & Chris Littlewood & Claire Rothery, 2024. "Rapid Assessment of the Need for Evidence: Applying the Principles of Value of Information to Research Prioritisation," PharmacoEconomics, Springer, vol. 42(9), pages 919-928, September.
  15. Irina Pokhilenko & Luca M. M. Janssen & Mickael Hiligsmann & Silvia M. A. A. Evers & Ruben M. W. A. Drost & Aggie T. G. Paulus & Leonarda G. M. Bremmers, 2021. "The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best–Worst Scaling Experiment," PharmacoEconomics, Springer, vol. 39(1), pages 99-108, January.
  16. Francesco Ramponi & Simon Walker & Susan Griffin & Steve Parrott & Colin Drummond & Paolo Deluca & Simon Coulton & Mona Kanaan & Gerry Richardson, 2021. "Cost‐effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross‐sectoral analysis of an alcohol misuse intervention," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 972-988, May.
  17. Fatimah, Alfariany & Britteon, Philip & Turner, Alex J & Anselmi, Laura & Gillibrand, Stephanie & Wilson, Paul & Sutton, Matt & Lau, Yiu-Shing, 2023. "Evaluating whole system reforms: A structured approach for selecting multiple outcomes," Health Policy, Elsevier, vol. 138(C).
  18. William V. Padula & Hui-Han Chen & Charles E. Phelps, 2021. "Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 19(2), pages 155-162, March.
  19. Candio, Paolo & Meads, David & Hill, Andrew J. & Bojke, Laura, 2021. "Taking a local government perspective for economic evaluation of a population-level programme to promote exercise," Health Policy, Elsevier, vol. 125(5), pages 651-657.
  20. Mark Sculpher & Stephen Palmer, 2020. "After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?," PharmacoEconomics, Springer, vol. 38(3), pages 247-257, March.
  21. Emma Frew & Nafsika Afentou & Hamideh Mohtashami Borzadaran & Paolo Candio & Irina Pokhilenko, 2022. "Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)," Applied Health Economics and Health Policy, Springer, vol. 20(5), pages 629-635, September.
  22. Sebastian Hinde & Helen Weatherly & Gabriella Walker & Lorna K. Fraser, 2021. "What Does Economic Evaluation Mean in the Context of Children at the End of Their Life?," IJERPH, MDPI, vol. 18(21), pages 1-11, November.
  23. Tuba Saygın Avşar & Xiaozhe Yang & Paula Lorgelly, 2023. "How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe," PharmacoEconomics, Springer, vol. 41(2), pages 123-138, February.
  24. Claudia Fischer & Susanne Mayer & Nataša Perić & Judit Simon, 2022. "Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review," Health Economics Review, Springer, vol. 12(1), pages 1-13, December.
  25. Lauren C Ramsay & Marina Richardson & Rafael N Miranda & Marian Hassan & Sarah K Brode & Elizabeth Rea & Beate Sander, 2023. "Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review," PLOS ONE, Public Library of Science, vol. 18(8), pages 1-13, August.
  26. Manuel Gomes & Elizabeth Murray & James Raftery, 2022. "Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice," PharmacoEconomics, Springer, vol. 40(4), pages 367-378, April.
  27. Jonathan Karnon & Brita Pekarsky, 2020. "Should Health Economic Evaluations Undertaken from a Societal Perspective Include Net Government Spending Multiplier Effects?," Applied Health Economics and Health Policy, Springer, vol. 18(4), pages 467-475, August.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.